Parker Hannifin Option Alert: Mar 21 $710 Calls at the Bid: 1475 vs 14 OI

Parker Hannifin Option Alert: Mar 21 $710 Calls at the Bid: 1475 @ $13.0 vs 14 OI; Ref=$696.77

Parker Hannifin Option Alert: Fri $680 Calls at the Bid: 1030 vs 1584 OI

Parker Hannifin Option Alert: Fri $680 Calls at the Bid: 1030 @ $18.5 vs 1584 OI; Ref=$696.61

Parker Hannifin (NYSE:PH) 주식

Parker Hannifin

Parker Hannifin started out in 1917 as Parker Appliance, selling pneumatic brakes. Through the acquisition of branded components, the firm has expanded into aerospace engines, agricultural and construction machinery, freight and passenger vehicles, and industrial automation equipment. Within these larger systems, Parker sells a wide array of small, critical pieces such as hydraulic, electromechanical, climate control, and filtration components. Many of its products are designed to work together, resulting in a high rate of cross-selling.

Analyst Color

Analyst Ratings

Tech

BURL

FOXA

NCLH

NVDA

PINS

SNOW

SPGI

UBER

골드만삭스 리서치가 새로운 해를 맞아 대담한 주식 선택과 2025년 시장을 형성할 다섯 가지 투자 테마를 조명했다. 무슨 일이 있었나: 목요일에 공유된 노트에서, 스티븐 크론(Steven Kron)이 이끄는 애널리스트 팀은 &#34;컨빅션 리스트(Conviction List)&#34; - 주목할 만한 투자 아이디어로 구성된 포트폴리오를 재조정했다.

골드만삭스, &#39;컨빅션 리스트&#39;에 3개의 주식 추가 및 2025년 주목해야 할 5가지 시장 동향

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

BLBD

USFD

목요일 오전 (현지 시간 기준) 미국 주식 선물 거래가 혼조세를 보이고 있는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다:

목요일 주목해야 할 주식: 일라이 릴리, US 푸즈, 블루 버드 그리고 종목

Parker Hannifin Corp

PHALA - United States Dollar

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming Group

PhaseBio Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals Inc

Invesco Fundamental High Yield Corporate Bond ETF

Phoenix Global 

PHARMARON BEIJING CO LTD by PHARMARON BEIJING CO LTD.

Pharmaron Beijing Co Ltd

PHARMAGREEN BIOTECH INC by Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc

Red Pulse Phoenix - TrueUSD

PHC Holdings Corp

PUHUI WEALTH INV MGMT NEW by Puhui Wealth Investment Management Co., Ltd.

Puhui Wealth Investment Management Co Ltd

PURE HARVEST CORPRATE GRP by Pure Harvest Corporate Group, Inc

Pure Harvest Corporate Group Inc

PANAMERA HOLDINGS CORP by Panamera Holdings Corporation

Panamera Holdings Corp

PURE HYDROGEN CRP LTD by Pure Hydrogen Corp Ltd.

Pure Hydrogen Corp Ltd

Healius Ltd

PhotoCure ASA

Pioneer Floating Rate Trust

Invesco S&P 500 Downside Hedged ETF

PT ASPIRASI HIDU U/ADR by PT Aspirasi Hidup Indonesia TBK

PT Aspirasi Hidup Indonesia Tbk

Morgan Stanley ETF Trust Parametric Hedged Equity ETF

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips NV

Phil-Good Products Inc

BiomX Inc

BiomX Inc Warrants (13/12/2023)

PETS AT HOME GRP UNSP/ADR by Pets at Home Group PLC

Pets at Home Group PLC

PHARMING GROUP NV ORD by Pharming Group NV

Park Ha Biological Technology Co., Ltd. - ordinary shares

Park Ha Biological Technology Co Ltd

PLDT Inc

PHI Group Inc

Phinia Inc

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corp

PHASE HOLOGRAPHIC IMAGNG by Phase Holographic Imaging PHI AB

PT HANJAYA MANDALA SAMPRN by PT Hanjaya Mandala Sampoerna Terbuka

PT Hanjaya Mandala Sampoerna Tbk

PIMCO High Income Fund

POLY PPTY GROUP CO ORD by Poly Property Group Co Ltd

Poly Property Group Co Ltd

PACIFICHEALTH LABS INC by PacificHealth Laboratories, Inc.

PETERSHILL PARTNERS PLC by PETERSHILL PARTNERS PLC.

Performant Healthcare, Inc. - Common Stock

Performant Healthcare Inc

Imagica Group Inc

PulteGroup Inc

PHARMACOM BIOVET INC by PharmaCom BioVet, Inc.

PharmaCom BioVet Inc

Pharma Mar SA

PHOENIX MECANO AG STEIN by PHOENIX MECANO AG STEIN AM RHEIN

Phoenix Mecano AG

PHINERGY LTD by PHINERGY LTD.

PHENOM RESOURCES CORP by Phenom Resources Corp

Phenom Resources Corp

Invesco Water Resources ETF

PHOSPHATE HOLDINGS INC by Phosphate Holdings, Inc.

Phosphate Holdings Inc

GrowLife Inc

PHILIP MORRIS CR AS ORD by PHILIP MORRIS CR AS

Philip Morris CR AS

Signify NV

PRIMARY HEALTH PROPERTIES by Primary Health Properties Plc.

Primary Health Properties PLC

PUSHPAY HLDGS LTD NEW by Pushpay Hldgs Ltd.

Phreesia Inc

PHARMARON BEIJING U/ADR by PHARMARON BEIJING CO LTD.

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd

Pharmagen Inc

PHarol SGPS SA

PENTHOUSE INTL INC by Penthouse International, Inc.

PACIFIC HOSP SUPPLY CO by Pacific Hospital Supply Co., Ltd.

Pioneer High Income Trust

Phunware Inc

Pharvaris NV

PHX Minerals Inc

PHX ENERGY SERVICES CORP by PHX Energy Services Corp.

PHX Energy Services Corp

PHAXIAM Therapeutics SA SPONSORED ADR NEW

Putnam ETF Trust Putnam ESG High Yield ETF

PGIM Active High Yield Bond ETF

IXICO PLC

Sprott Physical Gold Trust

PYROPHYTE ACQ CORP A by Pyrophyte Acquisition Corp.

Pyrophyte Acquisition Corp

Pyrophyte Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Pyrophyte Acquisition Corp Warrants(01/01/9999)

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 5 years by 17.63% on an annualized basis producing an average annual return of 33.72%. Currently, Parker Hannifin has a market capitalization of $80.66 billion. 
Buying $1000 In PH: If an investor had bought $1000 of PH stock 5 years ago, it would be worth $3,796.47 today based on a price of $626.38 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741100412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Parker Hannifin 5 Years Ago Would Be Worth Today

WIIM

AGCO

CMCO

GTES

LECO

REVG

SHYF

SPXC

Shares of machinery companies are trading lower amid overall market uncertainty after President Trump confirmed March 4 tariffs.

INLF

MVST

Shares of machinery companies are trading lower amid overall market weakness on US consumer and economic concerns.

Parker Hannifin's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) short percent of float has fallen 15.79% since its last report. The company recently reported that it has 1.03 million shares sold short, which is 0.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Parker Hannifin Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740155427_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Parker Hannifin has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Parker Hannifin's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Parker Hannifin's peer group average for short interest as a percentage of float is 2.97%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What Does the Market Think About Parker Hannifin?

Evercore ISI Group analyst David Raso maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Outperform and raises the price target from $777 to $824.

Price Target

Evercore ISI Group Maintains Outperform on Parker Hannifin, Raises Price Target to $824

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 20 years by 6.47% on an annualized basis producing an average annual return of 14.92%. Currently, Parker Hannifin has a market capitalization of $90.17 billion. 
Buying $1000 In PH: If an investor had bought $1000 of PH stock 20 years ago, it would be worth $16,192.00 today based on a price of $700.25 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739832308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Citigroup analyst Andrew Kaplowitz initiates coverage on Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Buy rating and announces Price Target of $795.

Initiation

Citigroup Initiates Coverage On Parker Hannifin with Buy Rating, Announces Price Target of $795

UBS analyst Amit Mehrotra maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Buy and lowers the price target from $842 to $805.

UBS Maintains Buy on Parker Hannifin, Lowers Price Target to $805

Stifel analyst Nathan Jones maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Hold and raises the price target from $689 to $691.

Stifel Maintains Hold on Parker Hannifin, Raises Price Target to $691

Keybanc analyst Jeffrey Holford maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Overweight and raises the price target from $775 to $790.

Keybanc Maintains Overweight on Parker Hannifin, Raises Price Target to $790

Wells Fargo analyst Joseph O'Dea maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Overweight and raises the price target from $710 to $775.

Wells Fargo Maintains Overweight on Parker Hannifin, Raises Price Target to $775

Barclays analyst Julian Mitchell maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Overweight and lowers the price target from $800 to $791.

Barclays Maintains Overweight on Parker Hannifin, Lowers Price Target to $791

Parker-Hannifin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) stock gained after reporting mixed second-quarter results and <a href="https://www.benzinga.com//node/43332999">updating its 2025 outlook.</a>
The company reported year-over-year sales decline to $4.742 billion and 1% organic growth, missing the consensus of $4.80 billion. Adjusted EPS for the quarter was $6.53, <a href="https://www.benzinga.com/earnings">above the consensus of $6.23.</a>
Orders were up 5% year-over-year, with Diversified Industrial North American businesses up 3% and Diversified Industrial International businesses up 4%. Orders in the Aerospace Systems segment increased 9% year-over-year.
Segment Sales: Diversified Industrial North America $1.928 billion (-8.6% Y/Y), Diversified Industrial International $1.325 billion (-5.7% Y/Y), and Aerospace Systems $1.49 billion (+14% Y/Y).
The total adjusted segment operating margin for the quarter was 25.6%, up 110 bps YoY.
"We delivered record segment operating margin across all businesses, record earnings per share and year-to-date cash flow from operations&#8230;We are encouraged to see industrial orders turn positive mainly in our longer-cycle businesses," commented Jenny Parmentier, Chairman and Chief Executive Officer.
Parker-Hannifin&#8217;s year-to-date cash flow from operations was 17.4% of sales, increasing 24% YoY to $1.7 billion. It held $395.51 million in cash and equivalents as of quarter-end.
"Looking ahead, we have updated our outlook for fiscal year 2025 to reflect stronger Aerospace growth, currency headwinds and a continued delay in the expected industrial recovery. Our strong cash generation creates capital deployment optionality, and we remain committed to our strategy of actively deploying capital to drive shareholder value," added Parmentier.
2025 Outlook updated: Parker now expects sales growth of (2%) to 1% (prior 0.5% &#8211; 3.5%), with organic <a href="https://www.benzinga.com/calendars/guidance">sales growth of 2% (prior 1.5% &#8211; 4.5%).</a>
The company updated its adjusted EPS guidance to $26.40 to $27.00 (prior $26.35 to $27.05) versus the $26.78 consensus.
Parker expects a total segment operating margin of approximately 22.7%, or approximately 25.8% on an adjusted basis (<a href="https://www.benzinga.com//node/41649455">prior approximately </a>22.6%, or approximately 25.7%, on an adjusted basis).
Price Action: Parker-Hannifin shares are trading higher by 5.58% at $702.96 at the last check Thursday.

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
12:37 PMFeb 19, 2025	CALL	$710.00	Mar 21, 2025	10	1476	1475	10543	14	TRADE	BULLISH
12:37 PMFeb 19, 2025	CALL	$680.00	Feb 21, 2025	-18	1030	1030	65	1584	TRADE	BULLISH

Comments

Parker Hannifin

Unusual Options Activity for

뉴스

파트너 / 기고자

벤징가 글로벌